The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
-- Lovenox(R) is the Low-Molecular Weight Heparin, Approved in the United States for the Broadest Range of Indications Sanofi-aventis announced today that the Food and Drug Administration (FDA) has ...
It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...
(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...
June 14, 2010 (Barcelona, Spain) — Major venous thromboembolism (VTE) and VTE-related mortality occurred in 2.2% of patients receiving oral dabigatran and in 4.2% of patients receiving subcutaneous ...
Orlando, FL - The investigational oral anticoagulant dabigatran looks to be as effective as the current standard of care, the low-molecular-weight heparin enoxaparin, in the prevention of venous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback